1. Home
  2. AREB vs XBIO Comparison

AREB vs XBIO Comparison

Compare AREB & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AREB

American Rebel Holdings Inc.

HOLD

Current Price

$0.30

Market Cap

5.5M

Sector

Industrials

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.65

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AREB
XBIO
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
5.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AREB
XBIO
Price
$0.30
$2.65
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
5.9M
28.6K
Earning Date
11-10-2025
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,014,691.00
$2,858,935.00
Revenue This Year
N/A
$1.99
Revenue Next Year
N/A
$20.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.30
52 Week Low
$0.29
$1.90
52 Week High
$875.00
$13.93

Technical Indicators

Market Signals
Indicator
AREB
XBIO
Relative Strength Index (RSI) 24.35 57.08
Support Level $0.44 $2.51
Resistance Level $0.55 $2.79
Average True Range (ATR) 0.09 0.14
MACD -0.01 0.06
Stochastic Oscillator 12.98 65.44

Price Performance

Historical Comparison
AREB
XBIO

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: